Lexaria Bioscience Common Stock

Lexaria Bioscience posts a common stock of $25K as of May 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Lexaria Bioscience's common stock was $0. The latest reading is $25K (period ending May 2026). Use the history and growth charts on this page for a longer lookback.

Common Stock is one piece of Lexaria Bioscience's financial statement story. At $25K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LEXX's common stock usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Lexaria Bioscience's other metric pages and overview cover the third.

Judging Lexaria Bioscience against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in common stock easier to interpret. Start with $25K here, then scan peer and history charts to see if the gap is persistent.